Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

H&Q Life Sciences Investors Announces Renewal of Share Repurchase Program


Friday, 22 Mar 2013 01:57pm EDT 

H&Q Life Sciences Investors announced that the Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2013. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period ending July 10, 2014. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund`s shares and the net asset value per share. The share repurchase program is intended to increase the Fund`s net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares. The amount and timing of repurchases will be at the discretion of Tekla Capital Management LLC, the Fund`s investment adviser. There is no assurance that the Fund will purchase shares at any specific discount levels or in any specific amounts or on any specific date. 

Latest Developments for Tekla Life Sciences Investors

Company Quote

26.08
-0.29 -1.10%
19 Dec 2014